ASCT-1201

N/A

Report date: 2026/03/09 20:02:04
NME

Base Information

Drug NameASCT-1201
Drug Alias NameASCT-1201ASCT1201
ClassificationOther
Mechanisms of ActionTumor necrosis factor α antagonists
TargetsTumor necrosis factor α
Therapy Area/IndicationsArthritis, RheumatoidArthritis, Psoriatic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlcamena Stem Cell Therapeutics Llc
China Registration ClassN/A

Develop Information

Active CompaniesAlcamena Stem Cell Therapeutics Llc
Inactive CompaniesN/A
Active IndicationsArthritis, RheumatoidArthritis, Psoriatic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A